[PCRX] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
30-Jul-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 110.34%
YoY- -26.69%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 178,023 169,467 169,411 135,590 75,505 102,604 84,107 13.29%
PBT 36,584 37,854 22,007 25,648 -7,311 1,127 2,599 55.32%
Tax 17,698 12,091 2,131 6,567 -42 -1,603 35 181.98%
NP 18,886 25,763 19,876 19,081 -7,269 2,730 2,564 39.44%
Tax Rate -48.38% -31.94% -9.68% -25.60% - 142.24% -1.35% -
Total Cost 159,137 143,704 149,535 116,509 82,774 99,874 81,543 11.77%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 10.61 15.20 11.73 14.07 -9.63 2.66 3.05 23.07%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.41 0.56 0.40 0.43 -0.17 0.07 0.06 37.71%
EPS Diluted 0.39 0.49 0.38 0.42 -0.17 0.06 0.06 36.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.